Coventry Health Care Announces Stockholder Approval Of Merger Agreement With Aetna
Coventry Health Care, Inc. (NYSE: CVH) announced that its stockholders
voted at the stockholder special meeting held earlier today to approve
the adoption of the previously announced merger agreement, dated as of
Coventry Health Care, Inc. (NYSE: CVH) announced that its stockholders voted at the stockholder special meeting held earlier today to approve the adoption of the previously announced merger agreement, dated as of August 19, 2012, as amended, providing for the acquisition of Coventry by Aetna. Of the 104,941,398 shares voting at today’s special meeting of stockholders, more than 99% voted in favor of the adoption of the merger agreement, which represented approximately 78% of Coventry’s total outstanding shares of common stock as of the October 15, 2012 record date. The completion of this transaction remains subject to customary closing conditions, including expiration of the federal Hart-Scott-Rodino antitrust waiting period and approvals of state departments of insurance and other regulators. Coventry and Aetna continue to expect that the transaction will be completed in mid-2013. Coventry Health Care ( www.coventryhealthcare.com) is a diversified national managed health care company based in Bethesda, Maryland, dedicated to delivering high-quality health care solutions at an affordable price. Coventry provides a full portfolio of risk and fee-based products including Medicare and Medicaid programs, group and individual health insurance, workers’ compensation solutions, and network rental services. With a presence in every state in the nation, Coventry’s products currently serve approximately 5 million individuals helping them receive the greatest possible value for their health care investment. Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. You can generally identify forward-looking statements by the use of forward-looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “explore,” “evaluate,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” or “will,” or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond Aetna’s and Coventry’s control. Statements in this document that are forward-looking, including the expected closing date of the merger, are based on management’s estimates, assumptions and projections, and are subject to significant uncertainties and other factors, many of which are beyond Aetna’s and Coventry’s control. Important risk factors could cause actual future events to differ materially from those currently expected by Coventry’s management, including, but not limited to the outcome of various litigation matters related to the proposed acquisition.
Coventry Health Care (NYSE:CVH) hit a new 52-week high Monday as it is currently trading at $50.34, above its previous 52-week high of $50.24 with 62,304 shares traded as of 10:06 a.m. ET. Average volume has been one million shares over the past 30 days.
Coventry Health Care (NYSE:CVH) hit a new 52-week high Thursday as it is currently trading at $49.42, above its previous 52-week high of $49.40 with 7,164 shares traded as of 9:31 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.